IMGN : Summary for ImmunoGen, Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets closed

ImmunoGen, Inc. (IMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.84 -0.05 (-2.65%)
At close: 4:00 PM EST
People also watch :
SGEN IMMU INCY EXEL CLDX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 1.89
Open 1.92
Bid 1.80 x 1000
Ask 1.88 x 500
Day's Range 1.83 - 1.95
52 Week Range 1.51 - 14.10
Volume 1,129,111
Avg. Volume 1,328,835
Market Cap 160.63M
Beta 2.03
PE Ratio (TTM) -1.03
EPS (TTM) -1.79
Earnings Date Jan 27, 2017 - Jan 31, 2017
Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 5.29
Trade prices are not sourced from all markets
  • Enzo Biochem, Inc. (ENZ): Are Hedge Funds Right About This Stock?
    Insider Monkey 12 hours ago

    Enzo Biochem, Inc. (ENZ): Are Hedge Funds Right About This Stock?

    Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]

  • Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)
    Insider Monkey 3 days ago

    Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over […]

  • ImmunoGen, Inc. Waits for Data
    Motley Fool last month

    ImmunoGen, Inc. Waits for Data

    Investors eagerly await data from the biotech's phase 3 trial, but there will be some earlier-stage data in the interim.

  • Capital Cube last month

    ETF’s with exposure to ImmunoGen, Inc. : November 1, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to ImmunoGen, Inc. Here are 5 ETF’s with the largest exposure to IMGN-US. Comparing the performance and risk of ImmunoGen, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ImmunoGen, Inc. :IMGN-US: Earnings Analysis: Q1, 2017 By the Numbers : October 31, 2016
    Capital Cube last month

    ImmunoGen, Inc. :IMGN-US: Earnings Analysis: Q1, 2017 By the Numbers : October 31, 2016

    Categories: Yahoo Finance Get free summary analysis ImmunoGen, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of ImmunoGen, Inc. – Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company and Johnson & Johnson (AMGN-US, BMY-US, LLY-US and JNJ-US) that have also reported for this period. Highlights ... Read more (Read more...)

  • ImmunoGen (IMGN) Reports Wider-than-Expected Loss
    Zacks last month

    ImmunoGen (IMGN) Reports Wider-than-Expected Loss

    ImmunoGen, Inc. (IMGN) reported a loss of 46 cents per share (excluding restructuring charge) in the three months ended Sept 30.

  • Thomson Reuters StreetEvents last month

    Edited Transcript of IMGN earnings conference call or presentation 28-Oct-16 12:00pm GMT

    Q1 2017 ImmunoGen Inc Earnings Call

  • Zacks last month

    The Zacks Analyst Blog Highlights: Biogen, Merck, Eli Lilly, AbbVie and ImmunoGen

    The Zacks Analyst Blog Highlights: Biogen, Merck, Eli Lilly, AbbVie and ImmunoGen

  • Associated Press last month

    ImmunoGen reports 1Q loss

    The Waltham, Massachusetts-based company said it had a loss of 51 cents per share. Losses, adjusted for restructuring costs, were 46 cents per share. The results did not meet Wall Street expectations. ...

  • AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint?
    Zacks last month

    AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint?

    AmerisourceBergen Corporation (ABC) is set to report fourth-quarter and fiscal 2016 results on Nov 2, before the opening bell.